Quarterly report · Q3
4885.TEDINET S100QLE5
Period2022-06-01 → 2023-02-28
Filed2023-04-14
StandardJapan GAAP
ConsolidatedNo
Data checks10 of 10 passed
Key figures · 38
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥4.6bn | 2022-06-01 → 2023-02-28 | Standalone | Net sales |
| Revenue | ¥5.7bn | 2021-06-01 → 2022-05-31 | Standalone | Net sales (5-year summary) |
| Revenue | ¥4.1bn | 2021-06-01 → 2022-02-28 | Standalone | Net sales |
| Operating income | ¥325m | 2022-06-01 → 2023-02-28 | Standalone | Operating income |
| Operating income | ¥355m | 2021-06-01 → 2022-02-28 | Standalone | Operating income |
| Ordinary income | ¥309m | 2022-06-01 → 2023-02-28 | Standalone | Ordinary income |
| Ordinary income | ¥423m | 2021-06-01 → 2022-05-31 | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥355m | 2021-06-01 → 2022-02-28 | Standalone | Ordinary income |
| Profit before tax | ¥309m | 2022-06-01 → 2023-02-28 | Standalone | Income before income taxes |
| Profit before tax | ¥354m | 2021-06-01 → 2022-02-28 | Standalone | Income before income taxes |
| Net income | ¥230m | 2022-06-01 → 2023-02-28 | Standalone | Profit loss |
| Net income | ¥456m | 2021-06-01 → 2022-05-31 | Standalone | Net income loss (5-year summary) |
| Net income | ¥300m | 2021-06-01 → 2022-02-28 | Standalone | Profit loss |
| Total assets | ¥5.0bn | at 2023-02-28 | Standalone | Assets |
| Total assets | ¥4.8bn | at 2022-05-31 | Standalone | Assets |
| Total assets | ¥4.6bn | at 2022-02-28 | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥3.1bn | at 2023-02-28 | Standalone | Liabilities |
| Total liabilities | ¥3.1bn | at 2022-05-31 | Standalone | Liabilities |
| Net assets / equity | ¥1.9bn | at 2023-02-28 | Standalone | Net assets |
| Net assets / equity | ¥1.7bn | at 2022-05-31 | Standalone | Net assets |
| Net assets / equity | ¥1.6bn | at 2022-02-28 | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥681m | at 2023-02-28 | Standalone | Cash and deposits |
| Cash and deposits | ¥865m | at 2022-05-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥61.46 | 2022-06-01 → 2023-02-28 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥21.53 | 2022-12-01 → 2023-02-28d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥123.79 | 2021-06-01 → 2022-05-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥81.55 | 2021-06-01 → 2022-02-28 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥10.26 | 2021-12-01 → 2022-02-28d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥58.55 | 2022-06-01 → 2023-02-28 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥112.56 | 2021-06-01 → 2022-05-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥73.62 | 2021-06-01 → 2022-02-28 | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥19 | 2021-06-01 → 2022-05-31 | Standalone | Dividend paid per share (5-year summary) |
| Equity ratio | 37.5% | at 2023-02-28 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 35.0% | at 2022-05-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 35.2% | at 2022-02-28 | Standalone | Equity to asset ratio (5-year summary) |
| Shares issued | 4,095,500 | at 2023-02-28 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 4,095,500 | at 2022-05-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 4,095,500 | at 2022-02-28 | Standalone | Total number of issued shares (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 30
| Segment | Item | Period | Value |
|---|---|---|---|
| jpcrp040300-q3r_E36350-000Chemical Products Businessreportable segment | revenue | 2022-06-01 → 2023-02-28 | ¥1.5bn |
| jpcrp040300-q3r_E36350-000Chemical Products Businessreportable segment | revenue external | 2022-06-01 → 2023-02-28 | ¥1.5bn |
| jpcrp040300-q3r_E36350-000Chemical Products Businessreportable segment | segment profit | 2022-06-01 → 2023-02-28 | −¥25m |
| jpcrp040300-q3r_E36350-000Healthy Food Businessreportable segment | revenue | 2022-06-01 → 2023-02-28 | ¥528m |
| jpcrp040300-q3r_E36350-000Healthy Food Businessreportable segment | revenue external | 2022-06-01 → 2023-02-28 | ¥528m |
| jpcrp040300-q3r_E36350-000Healthy Food Businessreportable segment | segment profit | 2022-06-01 → 2023-02-28 | −¥75m |
| jpcrp040300-q3r_E36350-000Pharmaceutical Businessreportable segment | revenue | 2022-06-01 → 2023-02-28 | ¥2.6bn |
| jpcrp040300-q3r_E36350-000Pharmaceutical Businessreportable segment | revenue external | 2022-06-01 → 2023-02-28 | ¥2.6bn |
| jpcrp040300-q3r_E36350-000Pharmaceutical Businessreportable segment | segment profit | 2022-06-01 → 2023-02-28 | ¥426m |
| —segment total | revenue | 2022-06-01 → 2023-02-28 | ¥4.6bn |
| —segment total | revenue external | 2022-06-01 → 2023-02-28 | ¥4.6bn |
| —segment total | segment profit | 2022-06-01 → 2023-02-28 | ¥325m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-06-01 → 2023-02-28 | ¥4.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-06-01 → 2023-02-28 | ¥4.6bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-06-01 → 2023-02-28 | ¥325m |
| jpcrp040300-q3r_E36350-000Chemical Products Businessreportable segment | revenue | 2021-06-01 → 2022-02-28 | ¥1.4bn |
| jpcrp040300-q3r_E36350-000Chemical Products Businessreportable segment | revenue external | 2021-06-01 → 2022-02-28 | ¥1.4bn |
| jpcrp040300-q3r_E36350-000Chemical Products Businessreportable segment | segment profit | 2021-06-01 → 2022-02-28 | −¥2m |
| jpcrp040300-q3r_E36350-000Healthy Food Businessreportable segment | revenue | 2021-06-01 → 2022-02-28 | ¥668m |
| jpcrp040300-q3r_E36350-000Healthy Food Businessreportable segment | revenue external | 2021-06-01 → 2022-02-28 | ¥668m |
| jpcrp040300-q3r_E36350-000Healthy Food Businessreportable segment | segment profit | 2021-06-01 → 2022-02-28 | ¥22m |
| jpcrp040300-q3r_E36350-000Pharmaceutical Businessreportable segment | revenue | 2021-06-01 → 2022-02-28 | ¥2.0bn |
| jpcrp040300-q3r_E36350-000Pharmaceutical Businessreportable segment | revenue external | 2021-06-01 → 2022-02-28 | ¥2.0bn |
| jpcrp040300-q3r_E36350-000Pharmaceutical Businessreportable segment | segment profit | 2021-06-01 → 2022-02-28 | ¥335m |
| —segment total | revenue | 2021-06-01 → 2022-02-28 | ¥4.1bn |
| —segment total | revenue external | 2021-06-01 → 2022-02-28 | ¥4.1bn |
| —segment total | segment profit | 2021-06-01 → 2022-02-28 | ¥355m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-06-01 → 2022-02-28 | ¥4.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-06-01 → 2022-02-28 | ¥4.1bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-06-01 → 2022-02-28 | ¥355m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 369
| Item | Context | Value | Unit |
|---|---|---|---|
| Information about officers (text) | FilingDateInstant | Text · Plus | |
| Regulations in accordance with which financial statements have been prepared financial information | CurrentYTDDuration | Text · Plus | |
| Note on independent audit financial information | CurrentYTDDuration | Text · Plus | |
| Description of fact that consolidated financial statements have not been prepared financial information | CurrentYTDDuration | Original text (Japanese)当社は、子会社がありませんので、四半期連結財務諸表を作成しておりません。 | |
| Quarterly balance sheet (text) | CurrentYTDDuration | Text · Plus | |
| Year to quarter end statement of income (text) | CurrentYTDDuration | Text · Plus | |
| Notes changes in accounting policies in accordance with changes in accounting standards etc quarterly financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Debtors notes regarding overdraft contracts and or loan commitments (text) | CurrentQuarterInstant_NonConsolidatedMember | Text · Plus | |
| Description of fact that quarterly statement of cash flows has not been prepared (text) | CurrentYTDDuration_NonConsolidatedMember | Text · Plus | |
| Notes regarding dividend (text) | Prior1YTDDuration_NonConsolidatedMember | Text · Plus | |
| Notes regarding dividend (text) | CurrentYTDDuration_NonConsolidatedMember | Text · Plus | |
| Notes segment information etc quarterly financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Footnotes regarding segment information table (text) | Prior1YTDDuration_NonConsolidatedMember | Text · Plus | |
| Footnotes regarding segment information table (text) | CurrentYTDDuration_NonConsolidatedMember | Text · Plus | |
| Notes revenue recognition quarterly financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes per share information quarterly financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes significant events after reporting period quarterly financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Other information financial statements etc (text) | CurrentYTDDuration | Text · Plus | |
| Information about company which provides guarantee to reporting company (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 10 of 10 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |